X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
STRIDES PHARMA SCIENCE Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Quarterly Results   (PLLB)

Here are the latest quarterly results of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE financial fact sheet and STRIDES PHARMA SCIENCE share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

STRIDES PHARMA SCIENCE Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m8,8848,4189,9567,4906,6426,6357,3267,945 
Other income Rs m731361223157218106778 
Turnover Rs m9,6158,77810,1797,6476,8606,7417,4047,953 
Expenses Rs m7,3157,5458,6446,2625,7765,8276,3306,674 
Gross profit Rs m1,5528461,1731,1666497589221,278 
Depreciation Rs m529511543391443429445407 
Interest Rs m592640619498455441485501 
Profit before tax Rs m1,16255234434-31-570379 
Tax Rs m175-3342-2-40-431663 
Profit after tax Rs m9878819343583854316 
Gross profit margin %17.510.111.815.69.811.412.616.1 
Effective tax rate %15.0-60.717.8-0.4125.8837.323.116.7 
Net profit margin %11.11.11.95.80.10.60.74.0 
Diluted EPS Rs 16.6 1.5 3.2 7.3 0.1 0.6 0.9 5.3  
Diluted EPS (TTM) Rs 64.9 61.9 52.7 28.6 12.1 11.3 9.0 7.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: STRIDES PHARMA SCIENCE 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   INDOCO REMEDIES  AMAR REMEDIES  TTK HEALTHCARE  DR. REDDYS LAB  ALKEM LABORATORIES  

Compare STRIDES PHARMA SCIENCE With:   INDOCO REMEDIES  AMAR REMEDIES  TTK HEALTHCARE  DR. REDDYS LAB  ALKEM LABORATORIES  

Compare STRIDES PHARMA SCIENCE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

ECB Minutes; Tech Mahindra's Buyback Plan and Top Stocks to Watch Out for Today(Pre-Open)

On Thursday, the Indian share markets ended higher led by gains in metals and pharma stocks. The BSE Sensex ended at 35,898, up 142 points.

Views on news

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 54 m (down 72.2% YoY). Sales on the other hand came in at Rs 7 bn (down 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Feb 22, 2019 09:41 AM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - ACTAVIS COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS